Core Viewpoint - The company, Baize Medical (02609), has been selected to be included in various Hang Seng Index series, effective from September 8, 2025, reflecting increased investor recognition of its operational performance and growth potential [1] Group 1: Inclusion in Hang Seng Index - Baize Medical will be included in the Hang Seng Composite Index, Hang Seng Composite Industry Index - Healthcare, Hang Seng Composite Small Cap Index, Hang Seng Healthcare Index, and other related indices [1] - The Hang Seng Composite Index covers the top 95% of total market capitalization of companies listed on the Hong Kong Stock Exchange, serving as a comprehensive market benchmark [1] Group 2: Impact on Market Presence - Inclusion in the Hang Seng Composite Index will qualify the company's shares for trading through the Hong Kong Stock Connect programs, enhancing accessibility for mainland Chinese investors [1] - The board anticipates that this inclusion will increase the company's visibility in the capital markets, improve trading liquidity, and further enhance its investment value [1]
佰泽医疗(02609)获纳入恒生指数系列成份股